These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18986360)

  • 21. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis.
    Kymionis GD; Goldman D; Ide T; Yoo SH
    Cornea; 2008 Feb; 27(2):228-9. PubMed ID: 18216583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological study of necrolytic acral erythema.
    Abdallah MA; Ghozzi MY; Monib HA; Hafez AM; Hiatt KM; Smoller BR; Horn TD
    J Ark Med Soc; 2004 Apr; 100(10):354-5. PubMed ID: 15080276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis.
    Katsarou A; Armenaka M; Vosynioti V; Lagogianni E; Kalogeromitros D; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):382-7. PubMed ID: 19207676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasis.
    Rivard J; Janiga J; Lim HW
    J Drugs Dermatol; 2006 Jun; 5(6):505-10. PubMed ID: 16774101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Necrolytic acral erythema: a review of the literature.
    Geria AN; Holcomb KZ; Scheinfeld NS
    Cutis; 2009 Jun; 83(6):309-14. PubMed ID: 19681342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
    Wollenberg A; Reitamo S; Atzori F; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
    Allergy; 2008 Jun; 63(6):742-50. PubMed ID: 18445188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 0.1% tacrolimus ointment for the treatment of intertrigo.
    Chapman MS; Brown JM; Linowski GJ
    Arch Dermatol; 2005 Jun; 141(6):787. PubMed ID: 15967933
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma cell balanitis treated with tacrolimus 0.1%.
    Moreno-Arias GA; Camps-Fresneda A; Llaberia C; Palou-Almerich J
    Br J Dermatol; 2005 Dec; 153(6):1204-6. PubMed ID: 16307659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study.
    Stefanaki C; Stefanaki K; Kontochristopoulos G; Antoniou C; Stratigos A; Nicolaidou E; Gregoriou S; Katsambas A
    J Dermatol; 2008 Nov; 35(11):712-8. PubMed ID: 19120765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Necrolytic acral erythema associated with hepatitis C: effective treatment with interferon alfa and zinc.
    Khanna VJ; Shieh S; Benjamin J; Somach S; Zaim MT; Dorner W; Shill M; Wood GS
    Arch Dermatol; 2000 Jun; 136(6):755-7. PubMed ID: 10871939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of tacrolimus ointment in vitiligo alone or in combination therapy.
    Berti S; Buggiani G; Lotti T
    Skin Therapy Lett; 2009 May; 14(4):5-7. PubMed ID: 19585060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unilateral multiple lichen striatus treated with tacrolimus ointment: a case report.
    Vukićević J; Milobratović D; Vesić S; Milosević-Jovćić N; Cirić D; Medenica L
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Mar; 18(1):35-8. PubMed ID: 19350187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacrolimus hydrate ointment inhibits skin plasma extravasation in rats induced by topical m-xylene but not capsaicin.
    Goto S; Kondo F; Ikai Y; Miyake M; Futamura M; Ito K; Sakamoto T
    Eur J Pharmacol; 2009 Apr; 608(1-3):91-6. PubMed ID: 19258015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
    Hartmann A; Bröcker EB; Hamm H
    Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rosacea/acne rosacea: efficacy of combination therapy of azithromycin and topical 0.1% tacrolimus ointment.
    Sehgal VN; Sharma S; Sardana K
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1366-8. PubMed ID: 18435734
    [No Abstract]   [Full Text] [Related]  

  • 37. Zinc-Responsive Necrolytic Acral Erythema in a Patient With Psoriasis: A Rare Case.
    Hou YC; Wu CY
    Int J Low Extrem Wounds; 2016 Sep; 15(3):260-2. PubMed ID: 27272315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ulcerative lichen planus of the sole: excellent response to topical tacrolimus.
    Al-Khenaizan S; Al Mubarak L
    Int J Dermatol; 2008 Jun; 47(6):626-8. PubMed ID: 18477162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granuloma faciale successfully treated with topical tacrolimus.
    Patterson C; Coutts I
    Australas J Dermatol; 2009 Aug; 50(3):217-9. PubMed ID: 19659988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
    Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.